- Home
- SUUN vs PDSB Comparison
SUUN vs PDSB Comparison
Compare SUUN & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUUN
- PDSB
- Stock Information
- Founded
- SUUN 2013
- PDSB 2005
- Country
- SUUN Canada
- PDSB United States
- Employees
- SUUN N/A
- PDSB N/A
- Industry
- SUUN
- PDSB Biotechnology: Pharmaceutical Preparations
- Sector
- SUUN
- PDSB Health Care
- Exchange
- SUUN Nasdaq
- PDSB Nasdaq
- Market Cap
- SUUN 75.1M
- PDSB 72.2M
- IPO Year
- SUUN N/A
- PDSB N/A
- Fundamental
- Price
- SUUN $1.92
- PDSB $1.17
- Analyst Decision
- SUUN Strong Buy
- PDSB Strong Buy
- Analyst Count
- SUUN 2
- PDSB 2
- Target Price
- SUUN $5.00
- PDSB $10.00
- AVG Volume (30 Days)
- SUUN 595.4K
- PDSB 582.9K
- Earning Date
- SUUN 09-30-2025
- PDSB 08-13-2025
- Dividend Yield
- SUUN N/A
- PDSB N/A
- EPS Growth
- SUUN N/A
- PDSB N/A
- EPS
- SUUN N/A
- PDSB N/A
- Revenue
- SUUN $25,798,969.00
- PDSB N/A
- Revenue This Year
- SUUN N/A
- PDSB N/A
- Revenue Next Year
- SUUN $46.21
- PDSB N/A
- P/E Ratio
- SUUN N/A
- PDSB N/A
- Revenue Growth
- SUUN N/A
- PDSB N/A
- 52 Week Low
- SUUN $1.23
- PDSB $0.85
- 52 Week High
- SUUN $6.43
- PDSB $4.29
- Technical
- Relative Strength Index (RSI)
- SUUN 51.64
- PDSB 45.12
- Support Level
- SUUN $1.68
- PDSB $1.15
- Resistance Level
- SUUN $2.15
- PDSB $1.31
- Average True Range (ATR)
- SUUN 0.23
- PDSB 0.09
- MACD
- SUUN -0.04
- PDSB -0.00
- Stochastic Oscillator
- SUUN 27.59
- PDSB 6.25
About SUUN SolarBank Corporation Common Stock
SolarBank Corp is an independent renewable and clean energy project developer and asset operator based in Canada and the United States. It is engaged in the development and operation of solar photovoltaic power generation projects in the province of Ontario and the state of New York. The company operates in two principal geographical areas - Canada and United States with a substantial portion of its overall revenue being generated from United States.
About PDSB PDS Biotechnology Corporation
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.